Savient Pharmaceuticals, Inc. (SVNT) Misses Q2 Loss Views by 13c
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Financial Fact:
Selling, general and administrative: 14.32M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Selling, general and administrative: 14.32M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) reported Q2 EPS of ($0.43), $0.13 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- The LGL Group (LGL) Misses Q2 EPS by 8c
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
